Categories Earnings, Technology

Despite headwinds, revenues grow 10% for Marvell Technology in Q1

Marvell Technology Group (NASDAQ: MRVL) on Thursday reported better-than-expected results, sending the stock up 2% during after-market hours.  

The chipmaker reported a 9.6% growth in revenues to $662  million in the first quarter of 2019. Adjusted EPS, meanwhile, halved year-over-year to 16 cents per share. Analysts were expecting the chipmaker to post Q1 earnings of 14 cents per share on revenues of $650.21 million.

Marvell stock has gained 34.5% so far this year.

Outlook

For the second quarter, the company projects revenue to be about $650 million, while adjusted earnings are expected to come in the range of $0.13 to $0.17 per share.

Marvell CEO Matt Murphy said, “With the production ramp of our first 5G products later this year, and a growing pipeline of new wireless infrastructure design wins, Marvell is well positioned to becoming a leading silicon supplier to this market.”

READ: THIS TIME ELON MUSK GETS AN AWARD FOR HIS TWEETS

Earlier this week, rival NXP Semiconductors (NASDAQ: NXPI) had announced its plan to acquire Marvell’s Wi-Fi Connectivity business, in a deal that is expected to enhance Marvell’s margins. The transaction is expected to close by March 2020.

Marvell and its peers have been facing the brunt of weak macros, reduction in spending from their clients and a shortage of CPUs, which has been reflected in their earnings. However, the company is seeing strong demand for its networking products from 4G and 5G deployments.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top